GlaxoSmithKline (GSK) United Kingdom (External organisation)

Description

Single domain antibodies that bind il-13

Abstract: Disclosed are ligands that have binding specificity for interleukin-13 (IL-13), or for IL-4 and IL-13. Also disclosed are methods of using these ligands. In particular, the use of these ligands for treating allergic asthma is described.

US20120093830A1 - United States
Application US12/992,718 events
2006-01-24 Priority to US76170806P
2009-05-13 Application filed by Inusha De Silva
2012-04-19 Publication of US20120093830A1

Period	19 Apr 2012
Held at	GlaxoSmithKline (GSK) United Kingdom, United Kingdom
Degree of Recognition	National